Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Idea to Innovation

University of Calgary

$58,250.00

Development of an auto-positioning mandibular protruder for treatment of sleep apnea

FY 2007-08

Summary
The project will develop an adaptive controlled mandibular protruder (ACMP). The ACMP is a medical device that will be used for the treatment of the 40+ million people who suffer from obstructive sleep apnea and high upper airway resistance. ACMP is an oral appliance designed and developed by Dr. John Remmers who is widely recognized as the founder of modern sleep apnea treatment (CPAP). Dr. Remmers ongoing work in this field has highlighted a need for new devices and management process that address low compliance issues associated with primary treatment options like CPAP. While oral appliances are not a new concept in the management of obstructive sleep apnea, current appliances, are known to cause dental and mandibular joint problems as a result of the forces needed to maintain the mandible in a fixed position throughout the night. The ACMP will respond to a number of measured physiologic parameters, continually optimizing the position of the mandible and minimizing the total forces applied to the mandible. The ACMP is expected to improve the therapeutic efficacy of dental devices, while minimizing side effects, such as tooth movement. The final development of the device will take advantage of technological advancements in miniaturization and physiologic monitoring, and produce an advanced prototype ready for regulatory testing at the end of the requested funding term.
Program
Idea to Innovation
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
356614-2007
Name nom
Remmers, JohnEdward
Department département
Medicine, Faculty of
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2007
Competition year année de concours
2007
Award amount
58250
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
9000
Research subject group en
Medical sciences
Research subject group fr
Sciences médicales
Research subject en
Medical sciences
Research subject fr
Sciences médicales
Partie
1
Nb partie
2
Application title
Development of an auto-positioning mandibular protruder for treatment of sleep apnea
Keyword
NA
Application summary
The project will develop an adaptive controlled mandibular protruder (ACMP). The ACMP is a medical device that will be used for the treatment of the 40+ million people who suffer from obstructive sleep apnea and high upper airway resistance. ACMP is an oral appliance designed and developed by Dr. John Remmers who is widely recognized as the founder of modern sleep apnea treatment (CPAP). Dr. Remmers ongoing work in this field has highlighted a need for new devices and management process that address low compliance issues associated with primary treatment options like CPAP. While oral appliances are not a new concept in the management of obstructive sleep apnea, current appliances, are known to cause dental and mandibular joint problems as a result of the forces needed to maintain the mandible in a fixed position throughout the night. The ACMP will respond to a number of measured physiologic parameters, continually optimizing the position of the mandible and minimizing the total forces applied to the mandible. The ACMP is expected to improve the therapeutic efficacy of dental devices, while minimizing side effects, such as tooth movement. The final development of the device will take advantage of technological advancements in miniaturization and physiologic monitoring, and produce an advanced prototype ready for regulatory testing at the end of the requested funding term.